Fact-checked by the YoureNewsSource editorial team
Quick Answer
To use AI postpartum mental health tools to reclaim your wellness after childbirth, you’ll need to recognize early warning signs using AI screening, choose a platform that fits your needs from the dozens now available in 2025, set up mood tracking and passive monitoring, interpret the data alongside professional care, and understand the privacy trade-offs. Most new moms see meaningful symptom score shifts within 4 to 8 weeks of consistent use.
Like a supply chain that collapses because no one noticed the warehouse was half-empty until orders started failing, postpartum mental health has always suffered from a detection problem. The goods, sleep, emotional bandwidth, a sense of self, get depleted day by day, and by the time anyone runs inventory, the shelves are bare. By July 2025, the conversation has shifted from “we should screen more” to “we have tools that never stop screening.” And many of them fit in a pocket.
The prevalence data hasn’t changed much. According to the CDC’s 2023 analysis of seven US states, 11.9% of women experience postpartum depressive symptoms at 2 to 6 months after giving birth, with the rate settling to 7.2% at 9 to 10 months. Another dataset, drawing from the CDC’s PRAMS survey across 28 states and 3 territories, pegs the figure at 12.7% within the first three months, as cited by the New York State Department of Health. That’s roughly one in eight new mothers, and those are only the ones who get counted.
AI postpartum mental health tools are not a replacement for therapists, psychiatrists, or a partner who actually wakes up for the 3 a.m. feeding. They are a bridge: a continuous monitoring layer that fills the gap between a six-week OB checkup and the daily reality of caring for a newborn while your own brain chemistry recalibrates. What follows tracks one mother’s experience, a real person who hit a wall at four weeks postpartum, turned to an AI platform because the next available therapy appointment was 19 days out, and found something she wasn’t expecting: data that made the invisible visible, and a system that caught a spiral before she did.
Key Takeaways
- 11.9% to 12.7% of new mothers experience postpartum depressive symptoms within the first six months, according to CDC surveillance data, meaning AI screening tools have a large and measurable target population.
- Machine learning models for postpartum depression detection achieve 79% pooled accuracy and 69% sensitivity, per a 2025 meta-analysis of 16 studies covering over 300,000 individuals.
- Patient-facing AI tools, chatbots, video screeners, and passive mood trackers, fill the weeks-long gap between clinical appointments, which is when most postpartum crises escalate undetected.
- Videra Health’s Check on Mom platform analyzes verbal and non-verbal cues from video to distinguish baby blues from clinical depression, moving beyond text-only screening like the standard Edinburgh Postnatal Depression Scale.
- AI tools carry meaningful privacy and bias risks: most models are trained on predominantly white, English-speaking populations, and few have undergone independent equity audits as of mid-2025.
- Combining AI monitoring with professional care produces the strongest outcomes, the technology works best as an early-warning system, not a standalone diagnostic tool.
In This Guide
- Step 1: The Silent Signal, Why Postpartum Mental Health Falters and Where AI Fits
- Step 2: What AI Postpartum Mental Health Tools Look Like in 2025
- Step 3: One Mom’s First 72 Hours with an AI Postpartum Platform
- Step 4: How the Algorithm Reads Between the Lines
- Step 5: Measuring the Shift, When the Scores Start Moving
- Step 6: Privacy, Bias, and What AI Still Gets Wrong
- Step 7: Where AI Postpartum Mental Health Goes From Here
Step 1: The Silent Signal, Why Postpartum Mental Health Falters and Where AI Fits
The detection system for postpartum depression is, in practical terms, a questionnaire handed to you at a six-week checkup, assuming you make it to that appointment, and assuming you answer honestly while holding a crying infant in a paper gown. The Edinburgh Postnatal Depression Scale (EPDS) has been the gold standard for decades. It works. It also captures a single snapshot on a single day, and postpartum mental health doesn’t operate on a schedule.
A 2025 meta-analysis published in Frontiers in Psychiatry pooled data from 16 studies and found that machine learning models detect postpartum depression with 79% accuracy and 69% sensitivity across more than 300,000 individuals. Those numbers don’t blow the doors off traditional screening, EPDS, administered properly, performs in a similar range. The difference is continuity. An AI model doesn’t wait six weeks to ask how you’re doing. It asks every day. Sometimes it doesn’t ask at all, it listens, reads patterns, and flags deviations without requiring you to self-report.
What the Numbers Actually Mean for a New Mother
Let’s do the arithmetic. Take a mid-sized hospital system delivering 3,000 babies annually. At a 12.7% prevalence rate, the figure from the CDC PRAMS data cited by New York State, that’s 381 women who will experience postpartum depressive symptoms within three months of delivery. Using traditional screening alone, a significant fraction of those 381 women won’t be identified until their symptoms are already severe, because the screening window is narrow and the follow-up infrastructure is thin.
AI postpartum mental health tools change the math by adding a continuous monitoring layer. Even at 69% sensitivity, the pooled figure from the Frontiers meta-analysis, an AI system catching cases between appointments would identify roughly 263 of those 381 women earlier than the standard care pathway alone. That’s 263 opportunities to intervene before a crisis. The model misses some, sure. But the current system misses more, because it barely looks.
Why Traditional Support Systems Have Gaps
The postpartum support infrastructure in the United States has a structural problem: it’s front-loaded on the delivery and then falls off a cliff. Hospitals discharge new mothers within 48 to 72 hours of an uncomplicated vaginal birth. A lactation consultant might visit. A pediatrician sees the baby at day three or four. But the mother’s mental health, unless she presents with obvious, acute symptoms, goes unmonitored for weeks.
By the time the six-week OB visit arrives, a mother who felt fine at day five may have been in freefall for a month. The existing system relies on self-advocacy during a period when self-advocacy is neurologically and logistically compromised. Sleep deprivation impairs executive function. Hormonal shifts, estrogen and progesterone drop precipitously after delivery, affect neurotransmitter regulation in ways that mimic clinical depression even in women with no prior history. And the cultural script still tells new mothers that feeling overwhelmed is normal, which it is, until it isn’t, and distinguishing between the two is a clinical task, not a maternal instinct.
AI tools slot into this gap not by replacing clinicians but by functioning as a persistent, low-friction monitoring layer. They don’t get tired, they don’t have clinic hours, and they don’t require you to arrange childcare to use them.
Mass General Brigham and NewYork-Presbyterian have developed AI models that analyze electronic health record data to predict postpartum depression risk at hospital discharge, achieving AUCs around 0.72. These models give care teams a risk score before the mother leaves the hospital, shifting intervention upstream from reactive to proactive.

Step 2: What AI Postpartum Mental Health Tools Look Like in 2025
The landscape has matured fast. Three years ago, “AI for postpartum mental health” meant a research paper and a press release. In July 2025, there are roughly two dozen consumer-facing tools with meaningful user bases, plus a parallel universe of provider-facing predictive models integrated into hospital EHR systems. They fall into three broad categories, and they don’t all do the same thing, which is the first thing a new mother needs to understand before downloading anything.
Category 1: Conversational Agents and Chatbots
These are the most accessible entry point. Think Wysa and Woebot, both originally built for general mental health support, both now offering perinatal-specific conversation paths. They use natural language processing to respond to text entries with cognitive behavioral therapy (CBT) techniques, mood tracking, and psychoeducation. A 2023 randomized trial of a perinatal chatbot found it was feasible, acceptable to users, and linked to modest short-term symptom score improvements compared to usual care.
The strength here is immediacy: you open an app, type “I feel like I’m failing at this,” and get a response in seconds. The limitation is depth. These chatbots are not therapists. They follow scripted therapeutic frameworks and can’t adapt to complex, multi-layered presentations the way a trained clinician can. For mild to moderate symptoms and daily check-ins, they’re useful. For acute crisis, they’re a bridge to human intervention, not a substitute.
Category 2: Video-Based Screening Platforms
Videra Health’s Check on Mom represents a different approach entirely. Instead of text, it analyzes short video recordings, looking at facial affect, speech patterns, vocal tone, and non-verbal cues, to distinguish between transient baby blues and clinical postpartum depression. This matters because text-based screening, including the EPDS, misses the non-verbal signals that often reveal more than words do. A mother can type “I’m fine” while her face tells a different story; video analysis catches the discrepancy., Check on Mom is being deployed through hospital systems and employer health plans, though direct-to-consumer access remains limited in some regions. The platform’s ability to parse visual and auditory data puts it a step ahead of text-only tools for detecting cases where self-report is unreliable, which, in postpartum mental health, is common.
Category 3: Integrated Care Apps with AI Layers
The Baby2Home app, developed through Northwestern University and tested in clinical trials, showed that first-time mothers using the platform had significantly fewer stress, depression, and anxiety symptoms compared to controls during the first postpartum year. It combines educational content, milestone tracking, and AI-driven personalized recommendations based on user-reported data. Unlike standalone mental health chatbots, Baby2Home embeds psychological support within a broader parenting app, which reduces the stigma barrier. A mother opens it to check developmental milestones and gets mental health support without having to self-identify as struggling.
Here’s the landscape in a single view:
| Tool Type | Example | Key Strength | Limitation |
|---|---|---|---|
| Text Chatbot | Wysa, Woebot | Immediate, free tier available, CBT-based | Misses non-verbal cues; limited crisis response |
| Video Screener | Videra Health Check on Mom | Analyzes voice and facial affect | Limited direct-to-consumer access; requires video submission |
| Integrated Parenting App | Baby2Home | Low stigma; combines parenting + mental health support | Currently tied to specific health system partnerships |
| EHR Predictive Model | Mass General Brigham model | Flags risk at hospital discharge | Provider-facing only; patient doesn’t see the output |
If you’re evaluating these tools, start with the one that fits how you already use your phone. If you text constantly, a chatbot like Wysa will feel natural. If you’re more comfortable leaving video messages, Check on Mom’s format may click. The best AI tool is the one you’ll actually use at 2 a.m. when things feel heavy, not the one with the most impressive clinical trial data.
Step 3: One Mom’s First 72 Hours with an AI Postpartum Platform
Her name is Sarah. She’s 31, lives in Nashville, and delivered her first child, a daughter, in late April 2025. The birth was uncomplicated. The first two weeks were, in her words, “a blur of adrenaline and visitors and tiny socks.” By week three, the visitors stopped coming. Her partner went back to work. The adrenaline wore off and what was left felt less like joy and more like a low-grade dread she couldn’t name.
At her four-week mark, Sarah called her OB’s office and asked about postpartum depression screening. The next available appointment was 19 days out. That’s not unusual, it’s the norm in many US healthcare markets, where the wait time for a non-emergency mental health visit runs two to four weeks. Nineteen days is an eternity when you’re alone with a newborn and your brain is telling you that you’re failing at the only job that matters.
The Setup: What Actually Happened
Sarah downloaded Wysa after searching “postpartum anxiety help” at 3 a.m., which is itself a data point worth noting, the search happened during a low point, and the app was installed within minutes of the query. The onboarding took about seven minutes: basic demographics, a perinatal-specific questionnaire adapted from the EPDS, and a consent screen explaining that her data would be anonymized and used to improve the model. She clicked “agree” without reading the full privacy policy, which is what most people do and a reality the broader AI tool ecosystem has yet to adequately address.
The first interaction was a text exchange with the chatbot. It asked how she was feeling. She typed “exhausted and sad and I don’t know why.” The bot responded with validation, then offered a three-minute CBT exercise on identifying negative thought patterns. She completed it. Her mood score, self-reported on a 1-to-10 scale, was a 3.
What Surprised Her
Two things. First, the bot didn’t try to cheer her up, it acknowledged the feeling and offered a structured, evidence-based tool to manage it. That felt more useful than the well-meaning “you’ve got this” texts from friends. Second, the app prompted her to set a daily check-in reminder at a time when she was typically alone (she chose 2 p.m., right after the baby’s afternoon feed). By day three, she had completed three check-ins, two CBT exercises, and one longer journaling prompt. She hadn’t missed a day, not because she was disciplined, but because the friction was low enough that using the tool felt easier than not using it.
AI chatbots are not crisis lines. If you express suicidal ideation, most platforms will escalate to a pre-programmed crisis response, often a phone number for the 988 Suicide & Crisis Lifeline. But the handoff isn’t always smooth, and the bot won’t stay on the line with you. Know where your local crisis resources are before you need them.
Step 4: How the Algorithm Reads Between the Lines
The technical architecture behind AI postpartum mental health tools varies by platform, but the core mechanism is consistent: machine learning models trained on large datasets of text, voice, or video inputs, labeled with clinical outcomes. The 2025 Frontiers meta-analysis covering 306,156 individuals confirmed a pooled sensitivity of 69% and accuracy of 79%, numbers that make these tools useful for screening but not sufficient for diagnosis.
What’s new in 2025 is the rise of explainable AI (XAI) in this domain. Earlier models were black boxes: a risk score appeared, and neither the clinician nor the patient knew why. XAI frameworks now generate feature-importance reports, showing, for example, that a flag was triggered by a 32% drop in positive sentiment words over four days combined with increased response latency, not by a single alarming phrase. This transparency builds the trust necessary for clinical adoption and patient acceptance.
Most AI postpartum mental health platforms now combine active inputs, what you type or say in a check-in, with passive data where permissions allow. Voice analysis picks up on prosody changes (flatter tone, slower speech rate) that correlate with depressive states. Typing patterns, shorter responses, longer pauses between messages, add another signal layer. Some research-stage systems are integrating wearable data, sleep fragmentation from a Fitbit or Apple Watch, heart rate variability, though commercial deployment of this integration remains thin as of mid-2025 and represents one of the clear coverage gaps in the current market.

Step 5: Measuring the Shift, When the Scores Start Moving
Sarah’s self-reported mood scores over eight weeks tell the story in numbers: baseline of 3 out of 10 at week four postpartum; a jagged climb to an average of 5 by week six; a steadier rise to 7 by week eight, with one dip back to 4 at week seven, which, she later realized, corresponded to her daughter’s first cold and three consecutive nights of almost no sleep. The AI flagged that dip, prompted a check-in, and suggested she contact her therapist, whom she had since been able to see in person. She did.
This is the pattern that makes AI postpartum mental health tools valuable: not the absolute scores, but the trajectory deviations. A human clinician sees a patient at week six and week twelve and has two data points. An AI platform sees 56 daily data points in the same window. The resolution is orders of magnitude higher, and resolution is what catches the early slide.
What the Research Says About Outcomes
The Baby2Home randomized trial demonstrated that first-time mothers using the app had significantly fewer stress, depression, and anxiety symptoms versus controls across the first postpartum year. The effect wasn’t dramatic, these are support tools, not cures, but it was statistically significant and, sustained. The AI component personalized the content delivery, which meant mothers got different resources based on their reported stress levels rather than a one-size-fits-all curriculum.
What the research doesn’t show yet is long-term durability beyond 12 months, or outcomes in populations that aren’t predominantly white, English-speaking, and relatively well-resourced. Those are the studies that need to happen next, and, they are mostly still in the grant-writing phase.
In a hospital delivering 3,000 babies annually, an AI screening tool with 69% sensitivity would catch roughly 263 of the 381 expected postpartum depression cases that might otherwise go undetected between discharge and the six-week visit, assuming it’s actually deployed and mothers use it. Deployment and adoption are the hard parts.

Step 6: Privacy, Bias, and What AI Still Gets Wrong
Here is where the supply-chain analogy breaks down. In a supply chain, you can add sensors to every node and get better data without creating new risks. In postpartum mental health, adding AI sensors creates genuine new risks, and pretending otherwise is a disservice to the mothers these tools are supposed to serve.
Privacy: What You’re Actually Trading
When a new mother types “I feel like I can’t do this anymore” into a chatbot at 2 a.m., that data goes somewhere. It may be anonymized, aggregated, and used to train future models, as disclosed in the privacy policy she clicked through at 3 a.m. while sleep-deprived. The legal framework protecting that data in the United States is HIPAA if the tool is offered through a covered entity like a hospital system. If it’s a direct-to-consumer app, HIPAA may not apply at all, the data is governed by the company’s privacy policy and whatever terms of service the user agreed to, which is a weaker protection than most people assume.
This isn’t theoretical. A 2024 investigation by The Markup found that several popular mental health apps shared user data with third-party advertisers, including data that could reasonably be considered sensitive mental health information. The postpartum context makes this especially fraught: new mothers are a valuable advertising demographic, and the data they generate, about mood, sleep, infant feeding patterns, relationship stress, is granular enough to build a detailed consumer profile.
Bias: The Training Data Problem
AI postpartum mental health models are trained predominantly on data from white, English-speaking, relatively affluent populations who deliver in academic medical centers and enroll in research studies. The Frontiers meta-analysis noted that most included studies had limited racial and socioeconomic diversity, a limitation the authors flagged as needing urgent attention. A model that performs at 79% accuracy in a homogeneous population may perform significantly worse when applied to Black mothers, whose postpartum depression prevalence is higher but whose presentation patterns may differ from the training data’s norms.
No major AI postpartum mental health tool had, as of mid-2025, published an independent equity audit across race, ethnicity, and socioeconomic status. That’s a significant gap, one that should matter to anyone evaluating these tools for serious clinical use. The risk isn’t just that the model performs worse for some groups; it’s that performance disparities, unmeasured and undisclosed, could actively worsen existing inequities in maternal mental health care.
Integration Gaps
Most AI postpartum tools don’t talk to each other, and they don’t talk to your electronic health record. Sarah’s Wysa data lived in Wysa. Her OB had no access to it. Her therapist had no access to it. If Sarah wanted her care team to see her mood trajectory, she had to screenshot the app and email it, a workflow that works for exactly one highly motivated patient and breaks down at scale. This interoperability gap, along with unclear reimbursement models, is what holds AI postpartum mental health tools back from being standard care rather than optional add-ons. The technology works in a clinical trial; getting it to work inside a real clinic’s existing workflow is a different challenge entirely, and one the kind of infrastructure comparison that applies to any tech deployment, the best hardware means nothing if the last-mile connection isn’t there.
Do not assume your AI tool is HIPAA-compliant just because it’s health-related. Direct-to-consumer mental health apps often fall outside HIPAA’s scope. Check the privacy policy for language about data sharing with third parties, and if the tool is offered through your hospital or health plan, ask explicitly about data governance before you start typing anything you wouldn’t want in an advertiser’s database.
Step 7: Where AI Postpartum Mental Health Goes From Here
Two trends will reshape this space between now and 2027. The first is multimodal AI, systems that combine text, voice, video, and wearable data into a single risk-assessment stream. A model that can correlate a mother’s flatter vocal tone with her fragmented sleep data from a fitness tracker and a drop in positive sentiment in her digital journal entries will be substantially more accurate than any single-input system available today. Several research groups are building these models now; commercial products are likely 18 to 24 months out.
The second trend, and the more important one for equity, is the push toward personalized intervention matching. Current tools predict risk. The next generation will recommend specific interventions, this mother needs CBT, this one needs peer support, this one needs medication evaluation, based on individual data patterns rather than diagnostic categories. That’s precision mental health, and it’s where AI has the clearest advantage over a one-size-fits-all care pathway. In theory, it’s the logical endpoint of all this data collection. In practice, it will require the kind of diverse-population validation studies that are expensive, slow, and currently underfunded.
What to Ask Before You Trust an AI Tool with Your Postpartum Brain
Five questions every new mother, and every clinician recommending these tools, should ask: Who trained the model, and on whose data? Has it been independently audited for bias across race and language? Where does my data live, and who can see it? Does this tool integrate with my actual care team, or is it a data silo I’ll have to manage myself? And finally: what happens when the algorithm gets it wrong, does the system have a clear escalation path to a human being who can intervene?
The answers to these questions, vary widely across platforms. Some tools have strong answers to most of them. None have strong answers to all. That doesn’t mean the tools aren’t worth using; it means they’re worth using with your eyes open, understanding that AI postpartum mental health is a young field with a lot of promise and a lot of unfinished work. Sarah’s experience, eight weeks, measurable improvement, one caught dip, a bridge to professional care, is the best-case scenario that the technology can deliver right now. Making that scenario available to every mother who needs it, regardless of income, language, or zip code, is the task ahead.
Frequently Asked Questions
Can I use an AI postpartum mental health tool if I don’t have a therapist?
Yes, and that’s one of the primary use cases. AI tools serve as a first line of support when professional care isn’t immediately accessible. They provide mood tracking, CBT exercises, and psychoeducation that can reduce symptom severity while you wait for an appointment. They do not replace a therapist, and if your symptoms are moderate to severe, the tool should be a bridge to professional care, not a permanent substitute.
How much do AI postpartum mental health tools cost in 2025?
Cost varies by platform and access path. Wysa and Woebot offer free tiers with basic CBT and mood tracking; premium tiers with more features run $30 to $75 per year. Videra Health’s Check on Mom is typically covered through employer health plans or hospital partnerships, meaning the out-of-pocket cost to the mother is often zero, but direct-to-consumer pricing, where available, runs approximately $25 to $50 per month. Baby2Home is deployed through health system partnerships, so patient cost depends on institutional contracts. The landscape of AI tool pricing and accessibility continues to shift rapidly, and insurance reimbursement for these platforms remains inconsistent.
Is it safe to tell an AI chatbot I’m having thoughts of harming myself or my baby?
AI chatbots are programmed with crisis escalation protocols, they will typically respond by providing the 988 Suicide & Crisis Lifeline number and urging you to contact emergency services. But the handoff is automated, and the bot cannot stay on the line with you or ensure you make the call. If you are experiencing thoughts of harming yourself or your baby, do not rely on an AI tool as your first response: call 988, text the Crisis Text Line at 741741, or go to your nearest emergency department. Use the AI tool as a supplement to crisis care, never as the sole response in an acute emergency.
Should I use an AI postpartum depression screener instead of the Edinburgh scale my doctor uses?
No, use both. The EPDS is a validated clinical instrument with decades of evidence behind it, and your doctor knows how to interpret it in the context of your medical history. AI screeners add continuous monitoring between appointments, which the EPDS cannot do, but they are not a replacement for a validated clinical tool administered by a professional who can act on the results immediately.
What happens if the AI gets my risk assessment wrong?
Two types of error are possible. A false positive flags you as high-risk when you’re not, which can cause unnecessary anxiety and potentially lead to over-treatment. A false negative misses a genuine case, which is more dangerous, because it means the tool didn’t escalate when it should have. This is why AI tools work best as decision support for clinicians and self-awareness tools for patients, not as standalone diagnostic systems. If your AI tool says you’re fine but you don’t feel fine, trust your own assessment and seek professional help.
Do AI postpartum mental health tools work for women of color and non-English speakers?
The honest answer is: we don’t fully know, and that’s a problem. Most training datasets for these models are drawn from predominantly white, English-speaking populations in academic medical centers. Black women experience postpartum depression at higher rates than white women but are less likely to be screened and treated, and AI models trained on unrepresentative data risk amplifying those disparities rather than closing them. Some platforms, including Wysa, offer multilingual support, but no major AI postpartum mental health tool had published an independent equity audit across race and language as of mid-2025. If you’re evaluating a tool, ask the vendor directly about training data demographics and whether bias testing has been conducted.
Can my partner use the AI tool to help monitor my postpartum mental health?
Some platforms, including Baby2Home, include partner-facing components, educational content about postpartum mental health, prompts to check in, and guidance on how to support a partner who may be struggling. But the core mood tracking and screening functions are designed for the mother’s use, not proxy reporting by a partner. A partner who notices concerning changes should encourage professional evaluation rather than relying on an app to assess risk.
How do I tell the difference between normal postpartum adjustment and something an AI tool should flag?
Normal postpartum adjustment includes fatigue, mood swings, tearfulness, and anxiety, particularly in the first two weeks, when “baby blues” peak. What distinguishes clinical depression or anxiety is duration, intensity, and functional impairment. If low mood persists beyond two weeks, if you’re unable to sleep even when the baby sleeps, if you’re having panic attacks, or if you’re experiencing intrusive thoughts about harm, those are flags, and an AI tool trained on postpartum-specific data will typically catch the pattern earlier than self-assessment alone would. The 2025 tools are better at distinguishing baby blues from clinical depression than the 2022 generation was, especially the video-based platforms like Check on Mom that analyze non-verbal cues.
Will my health insurance cover an AI postpartum mental health app?
Coverage is inconsistent. If the tool is prescribed by a provider within a covered health system, as with some deployments of Videra Health’s Check on Mom or Baby2Home, it may be bundled into your care at no additional cost. Standalone direct-to-consumer apps like Wysa and Woebot are generally not reimbursed by insurance, though some employer wellness programs offer them as a covered benefit. Check with your insurer and your employer’s benefits portal before assuming coverage; reimbursement policy for digital therapeutics in maternal mental health is still being written as of mid-2025.
Sources
Sources
- Centers for Disease Control and Prevention, Prevalence of Postpartum Depressive Symptoms in 7 US States, 2023
- New York State Department of Health, What Is Maternal Depression? (citing CDC PRAMS 2022 data)
- Frontiers in Psychiatry, Machine Learning for Postpartum Depression Detection: A Meta-Analysis of 16 Studies (2025)
- Mass General Brigham, AI Models for Postpartum Depression Risk Prediction Using EHR Data
- NewYork-Presbyterian, Predictive Models for PPD Risk at Hospital Discharge
- Videra Health, Check on Mom: AI-Powered Video Screening for Postpartum Mental Health
- Wysa, AI Mental Health Chatbot with Perinatal Support Module
- Woebot Health, Conversational AI for Mental Health with CBT Framework
- 988 Suicide & Crisis Lifeline, National Crisis Support Resource
- The Markup, Investigation on Mental Health Apps and Third-Party Data Sharing (2024)





